Northeast Investment Management Pfizer Inc Transaction History

Northeast Investment Management

$2.18 Billion
Q3 2024

A detailed history of Northeast Investment Management transactions in Pfizer Inc stock. As of the latest transaction made, Northeast Investment Management holds 100,099 shares of PFE stock, worth $2.67 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

100,099

Previous 105,558 5.17%

Holding current value

$2.67 Million

Previous $2.95 Million 1.93%

% of portfolio

0.13%

Previous 0.14%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $151,214 - $171,358	-5,459 Reduced 5.17%	100,099 $2.9 Million
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $626,624 - $734,287	-24,807 Reduced 19.03%	105,558 $2.95 Million
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $1.04 Million - $1.19 Million	-40,120 Reduced 23.53%	130,365 $3.62 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $2.27 Million - $2.94 Million	-86,745 Reduced 33.72%	170,485 $4.91 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $559,810 - $654,361	-17,445 Reduced 6.35%	257,230 $8.53 Million
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $299,073 - $346,021	-8,280 Reduced 2.93%	274,675 $10.1 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $43,762 - $56,972	-1,111 Reduced 0.39%	282,955 $11.5 Million
Q4 2022 Jan 27, 2023	SELL	$41.75 - $54.5 $232,881 - $304,001	-5,578 Reduced 1.93%	284,066 $14.6 Million
Q3 2022 Oct 28, 2022	SELL	$43.76 - $53.42 $1.3 Million - $1.59 Million	-29,793 Reduced 9.33%	289,644 $12.7 Million
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $846,659 - $1 Million	18,196 Added 6.04%	319,437 $16.7 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $434,167 - $537,988	9,490 Added 3.25%	301,241 $15.6 Million
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $1.87 Million - $2.77 Million	45,214 Added 18.34%	291,751 $17.2 Million
Q3 2021 Nov 08, 2021	BUY	$39.25 - $50.42 $680,987 - $874,787	17,350 Added 7.57%	246,537 $10.6 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $2.1 Million - $2.37 Million	58,342 Added 34.15%	229,187 $8.98 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $99,967 - $112,743	2,985 Added 1.78%	170,845 $6.19 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $107,304 - $136,447	3,206 Added 1.95%	167,860 $6.18 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $586,422 - $688,007	18,470 Added 12.63%	164,654 $6.04 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $34,969 - $42,422	-1,161 Reduced 0.79%	146,184 $4.78 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $9,514 - $13,594	352 Added 0.24%	147,345 $4.81 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $44,771 - $50,809	-1,360 Reduced 0.92%	146,993 $5.76 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $62,673 - $81,268	-1,929 Reduced 1.28%	148,353 $5.33 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $211,266 - $237,203	5,713 Added 3.95%	150,282 $6.51 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $142,837 - $156,930	-3,809 Reduced 2.57%	144,569 $6.14 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $44,779 - $51,053	1,164 Added 0.79%	148,378 $6.48 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $29,540 - $35,831	-857 Reduced 0.58%	147,214 $6.49 Million
Q2 2018 Aug 13, 2018	BUY	$32.98 - $35.16 $28,923 - $30,835	877 Added 0.6%	148,071 $5.37 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $120,045 - $139,269	-3,762 Reduced 2.49%	147,194 $5.22 Million
Q4 2017 Jan 29, 2018	SELL	$33.26 - $35.29 $23,581 - $25,020	-709 Reduced 0.47%	150,956 $5.47 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $4.7 Million - $5.18 Million	151,665	151,665 $5.41 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Investment Management with notifications on news.

Account

Northeast Investment Management Pfizer Inc Transaction History